GAPP 1 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Diabetes Mellitus

Novo Nordisk

Status: Completed

Conditions: Diabetes Mellitus, Type 1; Diabetes; Diabetes Mellitus, Type 2

Treatments: Behavioral: survey; Behavioral: No treatment given

Study type: Observational

Funder types: Industry

Identifiers

NCT01950650

GAPP1

U1111-1136-2507 (Other Identifier)

Details and patient eligibility

About

This study is conducted in Asia, Europe and in the United States of America. The aim of this study is to examine patient and physician beliefs regarding insulin therapy and the degree to which patients adhere to their insulin regimens.

Enrollment: 1,800 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• PATIENTS WITH DIABETES:
• Age 18 years or older
• Treated with insulin
• Type 1 or Type 2 diabetes
• PHYSICIANS:
• In practice for more than 1 year since completing residency
• See a minimum number of patients with diabetes per week (primary care physicians 5, specialists 10)
• Initiate insulin treatment for patients with diabetes

Trial design

1,800 participants in 2 patient groups

Patients with diabetes

Treatment:

Behavioral: No treatment given

Physicians

Treatment:

Behavioral: survey